Startseite Kongressberichte & Archiv Second Zurich Lung Cancer Symposium The Improvement of Survival in Metastatic NSCLC

The Improvement of Survival in Metastatic NSCLC - Chair: Rolf Stahel

  • Egbert Smit: Targeted Therapy for Patients with Oncogenic Driver NSCLC
  • Alessandra Curioni: Immune Checkpoint Inhibition for Patients with Tumors lacking Oncogenic Drivers
  • Discussion